Your browser doesn't support javascript.
loading
Clinical Characteristics and Outcomes in Advanced KRAS-Mutated NSCLC: A Multicenter Collaboration in Asia (ATORG-005).
Lee, Jiyun; Tan, Aaron C; Zhou, Siqin; Yoon, Shinkyo; Liu, Siyang; Masuda, Ken; Hayashi, Hidetoshi; Batra, Ullas; Kim, Dong-Wan; Goto, Yasushi; Tan, Sze Huey; Wu, Yi-Long; Lee, Dae Ho; Tan, Daniel S W; Ahn, Myung-Ju.
Afiliação
  • Lee J; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Tan AC; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.
  • Zhou S; Biostatistics and Epidemiology Unit, Clinical Trials and Epidemiological Sciences, National Cancer Centre Singapore, Singapore.
  • Yoon S; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Liu S; Guangdong Lung Cancer Institute, Guangdong Provincial Key Laboratory of Translational Medicine in Lung Cancer, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, School of Medicine, South China University of Technology, Guangzhou, People's Republic of China.
  • Masuda K; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Hayashi H; Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka-Sayama, Japan.
  • Batra U; Department of Medical Oncology, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, India.
  • Kim DW; Department of Internal Medicine, Clinical Trials Center, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.
  • Goto Y; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Tan SH; Biostatistics and Epidemiology Unit, Clinical Trials and Epidemiological Sciences, National Cancer Centre Singapore, Singapore.
  • Wu YL; Biostatistics and Quantitative Epidemiology, Singapore Health Services, Singapore, Singapore.
  • Lee DH; Oncology ACP, Duke-NUS Graduate Medical School, Singapore, Singapore.
  • Tan DSW; Guangdong Lung Cancer Institute, Guangdong Provincial Key Laboratory of Translational Medicine in Lung Cancer, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, School of Medicine, South China University of Technology, Guangzhou, People's Republic of China.
  • Ahn MJ; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
JTO Clin Res Rep ; 3(1): 100261, 2022 Jan.
Article em En | MEDLINE | ID: mdl-35024639
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Observational_studies Idioma: En Revista: JTO Clin Res Rep Ano de publicação: 2022 Tipo de documento: Article País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Observational_studies Idioma: En Revista: JTO Clin Res Rep Ano de publicação: 2022 Tipo de documento: Article País de publicação: Estados Unidos